Edwards Lifesciences nelle notizie
Innovazione globale nel cuore strutturale
Tamtam ha trovato 20 articoli recenti su Edwards Lifesciences.
- Edwards Lifesciences CVP Daniel Lippis sells $53k in stock By Investing.com
- Is Edwards Lifesciences (NYSE:EW) Entering A Stronger Phase?
- Edwards Lifesciences (NYSE:EW) VP Daniel Lippis Sells 619 Shares of Stock
- Why Edwards Lifesciences (EW) Stock Is Falling Today
- UBS reiterates Edwards Lifesciences stock rating on endpoint expectations By Investing.com
- Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
- Did FDA Approval Just Shift Edwards Lifesciences (EW) Investment Narrative?
- Edwards Lifesciences commemorates 20 years in Singapore improving patients’ lives across Asia
- Edwards Lifesciences (NYSE:EW) Share Price Breaks Above Two Hundred Day Moving Average - What's Next?
- Barclays Starts Edwards Lifesciences (EW) at Overweight
- Edwards Lifesciences to Host Investor Event in Conjunction With TCT
- What Does Expanded TAVR Coverage Mean for Edwards Lifesciences (NYSE:EW)?
- FDA Approves Edwards Lifesciences Autus Valve as First-Ever Expandable Pediatric Heart Valve
- Edwards Lifesciences (EW) Could Be 16% Undervalued As AUTUS Approval Sharpens The Debate
- Edwards Lifesciences wins FDA approval for AUTUS
- Edwards Wins FDA Approval for Expandable Pediatric Heart Valve
- Edwards Lifesciences Secures FDA Approval for First Expandable Pediatric Heart Valve
- JPMorgan Adjusts Price Target on Edwards Lifesciences to $105 From $100, Keeps Overweight Rating
- Edwards’ adjustable heart valve for children lands FDA approval
- A heart valve that grows with children shows what pediatric devices can become
Articoli raccolti da Tamtam e conservati quando riguardano l'azienda, dal più recente. Ognuno rimanda alla sua fonte.
Vendi ad aziende come Edwards Lifesciences?
Tamtam trova le aziende in linea con il tuo cliente ideale, analizza ogni account e ti dice chi contattare e quando.
Trova aziende simili